难治性特发性膀胱过度活动症接受A型肉毒毒素注射后反应不佳与不良事件的预测因素
OBJECTIVE: To ascertain whether a poor response and adverse events (voiding dysfunction and urinary tract infection) were predictable for first time botulinum toxin-A (BTX-A) injections in a patient cohort of refractory idiopathic overactive bladder with detrusor overactivity.…
要点
- 男性是BTX-A注射后反应不佳的独立预测因素(OR 5.45)。
- 低最大尿流率、男性、女性子宫切除术史预测需CISC。
- 接受CISC的患者尿路感染风险增加(OR 5.26)。
核心结论
- 男性与BTX-A注射反应不佳及CISC风险增加相关,低最大尿流率和女性子宫切除术史增加CISC风险,CISC与UTI风险增加相关。
关键数值与推荐
- 反应不佳定义为UDI-6问卷评分下降小于16.7。
临床怎么用
- 这些因素可用于咨询或选择患者时参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To ascertain whether a poor response and adverse events (voiding dysfunction and urinary tract infection) were predictable for first time botulinum toxin-A (BTX-A) injections in a patient cohort of refractory idiopathic overactive bladder with detrusor overactivity. METHODS: Patients who received BTX-A injections for the first time between the dates of March 2004-August 2017 were analyzed in this single center study. Urogenital Distress Inventory short form (UDI-6) questionnaires were collected both preinjection and postinjection prospectively. A poor response was defined as a decrease of less than 16.7 on the UDI-6 questionnaire. Additional information was gathered from patient records in a retrospective fashion. Predictors of poor response, voiding dysfunction, and UTI were analyzed with multivariate logistic regression analysis. RESULTS: Seventy-four patients were analyzed. The only predictor of poor response was male gender (OR, 5.45; 95% CI 1.83-16.47; P = .002). Lower maximum urinary flow rates (OR, 0.91; 95% CI, 0.83-0.99; P = .023), male gender (OR, 5.14; 95% CI 1.41-18.72; P = .013), and hysterectomy in females (OR, 4.55; 95% CI, 1.09-18.87; P = .038) were predictors of clean intermittent self catheterisation (CISC). There was an increased risk of UTIs in patients who performed CISC (OR, 5.26; 95% CI 1.38-20.0; P = .015). CONCLUSION: Male gender was associated with a poor response to BTX-A injections and increased risk of CISC. Lower maximum urinary flow rates and women with hysterectomies were at increased risk of requiring CISC postinjection. Performing CISC was associated with increased risk of UTI. These factors could be helpful when counselling or selecting patients.
引用
- Abrar M, Stroman L, Malde S, et al. Predictors of Poor Response and Adverse Events Following Botulinum Toxin-A for Refractory Idiopathic Overactive Bladder. Urology. 2019. PMID: 31626856. doi:10.1016/j.urology.2019.08.054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。